Gilead Sciences | Kreditur Perdagangan

Harga Saham
154.98
Perubahan Harian
3.17 2.09%
Bulanan
24.91%
Tahunan
48.90%
Q1 Perkiraan
150.18




Kreditur Perdagangan Perubahan Tanggal
AbbVie USD 32.25B 1.2B 2025-06
Agios Pharmaceuticals USD 18.36M 1.2M 2025-12
ALKERMES USD 68M 31.21M 2025-09
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Amgen USD 20.89B 1.25B 2025-12
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Coherus Biosciences USD 24.89M 12.73M 2025-09
Eli Lilly USD 5.38B 1.12B 2025-12
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Glaxosmithkline GBP 21.07B 7.42B 2025-09
Incyte USD 1.63B 1.46B 2025-12
J&J USD 11.99B 2.37B 2025-12
Merck USD 4.15B 102M 2025-09
Moderna USD 317M 50M 2025-12
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Novartis USD 4.56B 49M 2025-09
Pfizer USD 5.02B 142M 2025-09
PTC Therapeutics USD 36.62M 169.69M 2025-09
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 22.93B 927M 2025-12
Sarepta Therapeutics USD 94.02M 42.69M 2025-09
United Therapeutics USD 468M 36M 2025-09
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12


Gilead Sciences Kreditur Perdagangan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Feb 2026.